Sure, but kids react differently to vaccine doses so figuring out how much to give is also tricky. So there’s a phase one trial for dosing, followed by the larger phase 2/3 trial on whether it works and how well. I suspect they may just take a short cut and look at antibodies and call it good enough since kids are rarely symptomatic so getting enough of them for good stats could be hard and/or expensive.
The original adult covid trials started in mid March’20 and it was clearly a public health hazard to allow them to even be considered at the FDA before the Nov’20 election. Lots of our current elected officials told me so, while PFE slow rolled their trial and refused to hand over the interim results to their committee or the FDA. Oops. So they didn’t get their EUA from the FDA til mid Dec.
So the PFE trial for kids 5-12 began in late Mar’21, so you’d think that would be on a similar schedule to be approved by late Dec’21 if it followed the same, already very accelerated timing, of the adult covid vaccines.
The article was suggesting it could be 2 months sooner. I suspect if they continued on the same path, the end of the year would be a reasonable time. Of course if they create (have created?) a covid outbreak emergency by demanding all the kids go back to school in person, now the politicians (who need to do Something, since a lot of what they’ve been doing has gone Badly) and the vaccine companies (who are happy to sell more shots) can both get together and pressure the FDA to approve this early before the safety and efficacy data is all in.